Oxidative stress, redox signalling and endothelial dysfunction in ageing-related neurodegenerative diseases: a role of NADPH oxidase 2
Mechanisms and assessment of statin-related muscular adverse effects
Thiopurine monitoring in children with inflammatory bowel disease: a systematic review
The pharmacokinetics and pharmacodynamics of denosumab in patients with advanced solid tumours and bone metastases: a systematic review
Medication reviews for nursing home residents to reduce mortality and hospitalization: systematic review and meta-analysis
Tolerability, pharmacokinetics and pharmacodynamics of TA-8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects
Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling
Concomitant oral and intravenous pharmacokinetics of trametinib, a MEK inhibitor, in subjects with solid tumours
Understanding the effect of the HCV polymerase inhibitor mericitabine on early viral kinetics in the phase 2 JUMP-C and PROPEL studies
Population pharmacokinetics and pharmacodynamics of BYL719, a phosphoinositide 3-kinase antagonist, in adult patients with advanced solid malignancies
Effects of HM30181, a P-glycoprotein inhibitor, on the pharmacokinetics and pharmacodynamics of loperamide in healthy volunteers
Retrospective evaluation of methotrexate elimination when co-administered with proton pump inhibitors
Population pharmacokinetic modelling to assess the impact of CYP2D6 and CYP3A metabolic phenotypes on the pharmacokinetics of tamoxifen and endoxifen
Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin
A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time
Effect of the UK's revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment
Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study
Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran
Pharmacoepidemiologic and in vitro evaluation of potential drug–drug interactions of sulfonylureas with fibrates and statins
Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment
S -Nitrosoglutathione improves haemodynamics in early-onset pre-eclampsia
Assessing the harms of polypharmacy requires careful interpretation and consistent definitions
Response to: Assessing the harms of polypharmacy requires careful interpretation and consistent definitions
Effect of thrombopoietin-receptor agonists on a proliferation-inducing ligand (APRIL) plasma levels in patients with immune thrombocytopaenia
Corrigendum